lysine has been researched along with glucagon-like peptide 1 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Agersø, H; Huusfeldt, PO; Johansen, NL; Knudsen, LB; Madsen, K; Nielsen, PF; Pedersen, FZ; Thøgersen, H; Wilken, M | 1 |
| Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; Irwin, N; Mooney, MH; O'Harte, FP | 2 |
| Chae, SY; Jin, CH; Lee, KC; Lee, S; Shin, HJ; Youn, YS | 1 |
| Chae, SY; Choi, YG; Jung, SY; Lee, DS; Lee, KC; Son, S | 1 |
| Andersen, JM; Bak, MJ; Bügel, S; Dragsted, LO; Giraudi-Futin, AC; Holst, JJ; Larsen, LH; Lauritzen, L; Monošík, R; Nielsen, J; Poulsen, MW | 1 |
| Chen, Q; Fu, C; Li, H; Wang, L; Wang, Q; Wang, X; Yang, L; Zhao, Q; Zheng, F | 1 |
| Masiques, NE; Müller, M; Navarro, M; Roura, E; Tilbrook, A; van Barneveld, R; Xu, C | 1 |
1 trial(s) available for lysine and glucagon-like peptide 1
| Article | Year |
|---|---|
Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals.
Topics: Adult; Appetite; Blood Glucose; Body Mass Index; Cross-Over Studies; Diet; Endothelium; Energy Intake; F2-Isoprostanes; Female; Ghrelin; Glucagon-Like Peptide 1; Glycation End Products, Advanced; Hot Temperature; Humans; Inflammation; Insulin; Lysine; Male; Middle Aged; Overweight; Oxidative Stress; Peptide YY; Postprandial Period; Steam; Triglycerides | 2014 |
7 other study(ies) available for lysine and glucagon-like peptide 1
| Article | Year |
|---|---|
Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.
Topics: Acylation; Amino Acid Sequence; Animals; Cell Line; Chromatography, High Pressure Liquid; Cricetinae; Diabetes Mellitus, Type 2; Fatty Acids; Glucagon; Glucagon-Like Peptide 1; Kidney; Lysine; Molecular Sequence Data; Peptide Fragments; Peptides; Protein Precursors; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Swine | 2000 |
Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).
Topics: Adenylyl Cyclases; Amino Acid Substitution; Animals; Blood Glucose; Cells, Cultured; Cricetinae; Cyclic AMP; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Fibroblasts; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glutamic Acid; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Lung; Lysine; Mice; Mice, Obese; Peptide Fragments; Peptides; Receptors, Glucagon; Spectrometry, Mass, Electrospray Ionization | 2004 |
Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues.
Topics: Alanine; Animals; Blood Glucose; Cell Line; Cricetinae; Cricetulus; Cyclic AMP; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Injections, Intraperitoneal; Insulin; Insulin Secretion; Islets of Langerhans; Lysine; Mice; Mice, Obese; Palmitates; Peptide Fragments; Protein Precursors; Radioligand Assay; Receptors, Glucagon; Valine | 2004 |
Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery.
Topics: Absorption; Administration, Oral; Animals; Binding Sites; Biotin; Biotinylation; Blood Glucose; Diabetes Mellitus, Type 2; Enzyme Stability; Glucagon-Like Peptide 1; Hypoglycemic Agents; Injections, Intraperitoneal; Intestinal Mucosa; Lysine; Mice; Peptide Hydrolases; Polyethylene Glycols; Rats; Sensitivity and Specificity | 2008 |
The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics.
Topics: Animals; Antigens; Diabetes Mellitus; Diabetes Mellitus, Type 2; Exenatide; Fatty Acids; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Half-Life; Hypoglycemic Agents; Lysine; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Palmitic Acid; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Venoms | 2010 |
Genetically Encoding a Lipidated Amino Acid for Extension of Protein Half-Life in vivo.
Topics: Amino Acids; Animals; Escherichia coli; Genetic Code; Glucagon-Like Peptide 1; Half-Life; Lipids; Lysine; Mice; Mice, Inbred ICR | 2019 |
Leucine (and lysine) increased plasma levels of the satiety hormone cholecystokinin (CCK), and phenylalanine of the incretin glucagon-like peptide 1 (GLP-1) after oral gavages in pigs.
Topics: Animals; Cholecystokinin; Glucagon-Like Peptide 1; Glucose; Incretins; Leucine; Lysine; Male; Phenylalanine; Satiation; Swine | 2023 |